Neurovigil Company
NeuroVigil is a leading neurotechnology revolutionizing EEG analysis for clinical trials, communication and space applications.
Last Funding Type:
Series B
Funding Status:
Early Stage Venture
Headquarters:
Moffett Field, California, United States
Founded Date:
2007-02-05
Last Funding Date:
2015-05-01
Estimated Revenue:
$1M to $10M
Investors Number:
3
Industry:
NeuroTech